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Goal: Magnetic resonance imaging (MRI) is the preferred modality for research
on structural age-related brain changes. However, computed tomography (CT) is
widely available and has practical and cost advantages over MRI for large-scale
brain imaging research studies in acutely unwell patients. However, the relation-
ships between MRI and CT measures of white matter hyperintensities (WMH)
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and atrophy are unclear. We examined the relationships between visual ratings
of WMH, atrophy, and old infarcts in patients who had both CT and MRI scans.
Materials and Methods: Patients who had both CT and MRI scans in the Inter-
national Stroke Trial-3 were studied. In both modalities, 2 raters independently
completed standardized visual rating scales for WMH, and for central and su-
perficial atrophy using a 5-point scale. In addition, 1 rater recorded old infarcts
according to size and location. Findings: Seventy patients with a mean age of 69
years were studied. There were moderate to substantial intrarater CT–MRI agree-
ments for periventricular components of WMH scales (weighted Κappa =
.55-.75). Agreements for basal ganglia ratings were lower (weighted Κappa = .18-
.44), partly because of the misclassification of prominent perivascular spaces. Atrophy
scales showed moderate to substantial CT–MRI agreements (weighted Κappa = .44-
.70). MRI was more sensitive in the detection of smaller infarcts and cavitated
lesions. Conclusions: Standardized visual rating scales of white matter lesions and
atrophy mostly show substantial agreement between CT and MRI. Clinical CT
scans have a strong potential for wider exploitation in research studies, particu-
larly in acutely unwell populations. Key Words: Computed tomography—magnetic
resonance imaging—cerebral atrophy—white matter lesions—validity.
© 2018 The Authors. Published by Elsevier Inc. on behalf of National Stroke
Association. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
Introduction
Computed tomography (CT) is very commonly per-
formed in older patients admitted to hospital with acute
conditions such as stroke, reduced level of conscious-
ness, and delirium. Magnetic resonance imaging (MRI)
provides advantages over CT with respect to resolu-
tion, gray–white matter differentiation, and range of
modalities, but it is clinically used less frequently, espe-
cially in acutely unwell populations. This is because CT
is comparatively better tolerated, more rapid, less ex-
pensive, and more available than MRI. With the advent
of the systematic electronic collection of clinical data (e.g.,
cognitive status) and the availability of data linkage, there
is an enormous unfulfilled potential for exploitation of
the large numbers of routinely performed CT scans in
relation to acute and long-term clinical outcomes. Recent
studies provide evidence of the value of cross-sectional
and longitudinal CT scanning in predicting outcomes and
understanding the neural substrates. For example, in stroke
patients, cerebral atrophy on routine CT scans was as-
sociated with a higher risk of institutionalization at 3 years,1
while pre-existing signs on CT predicted reduced inde-
pendence at 6 months and increased symptomatic
hemorrhage post–ischemic stroke2 (Figure 1).
CT measures of atrophy and white matter lesions have
been evaluated against MRI reference standards. For
example, 1 study found very high correlations between
CT and MRI measurements of perihemorrhagic edema
volumes after intracerebral hemorrhage (Pearson corre-
lation coefficient R2 = .96, slope of 1.05, P < .01), although
cerebral atrophy was not assessed.3 High intraobserver
agreements were found for ratings of global cerebral
atrophy (Kappa = .83), medial temporal lobe atrophy
(Kappas = .88 [left], .86 [right], and Fazekas’ subcortical
WMH .79) between MRI and CT in 31 memory clinic
outpatients.4 Other studies report comparable findings.5-7
However, the evidence base remains small, and there
remains uncertainty over the relationships between CT
and MRI measures of white matter hyperintensities (WMH)
and atrophy. Therefore, here we compared qualitative as-
sessment of WMH, atrophy, and old infarcts in a group
of patients in the third International Stroke Trial who had
undergone both CT and MRI scanning within the acute
phase of their illness.
Materials and Methods
Participants
We used anonymized CT and MRI scans from the In-
ternational Stroke Trial-3 (IST-3), an international
multicenter, randomized controlled trial. The IST-3 study
was approved by the Scotland Research Ethics Commit-
tee and by ethics committees and other regulatory bodies
of all participating countries, hospitals, and institutions.
All patients, or a legal proxy if the patient lacked ca-
pacity, provided written informed consent.
Imaging
We used 70 paired CT and MRI scans performed clin-
ically and as part of research, with a short delay (hours
or a few days) between CT and MRI (CT always first).
Anonymized clinical spiral or multislice brain CT and
MRI including T2, FLAIR, and DTI sequences were stored
digitally and analyzed on a Picture Archiving and Com-
munication System. Raters were blind to MRI scans at
the time of CT analysis and vice versa. All CT scans were
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analyzed first followed by all MRI scans several weeks
later. For the intrarater reliability calculations, 1 rater (K.F.)
repeated the CT analysis months after the initial scoring
and was blind to the original results.
Analyses
Visual ratings by 2 raters (K.F. and V.C.) included deep
and superficial atrophy, which were scored separately ac-
cording to a previously validated 5-point scheme.8 In
addition, WMHs were rated according to the Age-
Related White Matter Change (ARWMC) scale (frontal,
parieto-occipital, and basal ganglia all rated on 4-point
scales; the temporal and infratentorial aspects of this scale
were omitted), van Swieten’s scale (anterior and poste-
rior periventricular lesions rated separately on 3-point
scales), and Fazekas’ scale.5,9,10 Although Fazekas’ scale
was devised in MRI, we applied it in the same way to
CT: this scale comprises two 4-point scales for assessing
periventricular lesions and deep WMHs (0, absence; 1,
cap of pencil-thin PVH or punctate focal deep WMH; 2,
smooth halo PVH or early confluence of focal deep WMH;
3, irregular PVH extending into the deep white matter
or large confluent areas of deep WMH). Old infarct re-
cording was performed by 1 experienced neuroimaging
research scientist (K.F.) according to a scheme devised
for coding the location and extent of old and acute
strokes.2,11 Criteria for lacunar infarcts were (1) ≥3, ≤20 mm
(maximal dimension) and (2) typical location, for example
in subcortical gray matter, internal or external capsule,
or deep white matter as well as cerebellum and brain
stem. The volume of presumed lacunar infarcts was cal-
culated by multiplying the maximal dimensions in 2
perpendicular planes on an axial slice, the number of slices
in which the lesion occurred and the slice thickness.
Statistical Analysis
Weighted Kappa values with linear weighting were used
(IBM SPSS Statistics for Windows, Version 19.0; IBM Corp.,
Armonk, NY), and agreement was interpreted accord-
ing to Landis and Koch: <0 = less than chance; .01-
.20 = slight; .21-.40 = fair; .41-.60 = moderate; .61-.80 =
substantial; .81-.99 = almost perfect.12 McNemar’s
test of marginal homogeneity (MH by Uebersax, http://
www.john-uebersax.com/stat/mh.htm) were also applied
to examine the symmetry between CT and MRI scores
and for inter-rater reliability within CT.
Results Sample
The median age of the patients was 76.66 years
(interquartile range = 27.48), and 43 were men (61%).
Figure 1. Examples of misclassification of old infarcts between CT and MRI. A small lacunar infarct was just visible on CT (A) but below the size
threshold for recording. The same lesion appeared larger on T2w MRI (B). A small cortical lesion missed on CT (C) was obvious on FLAIR MRI due to
tissue signal changes (D). Low attenuation in the external capsule was recorded as an old infarct on CT (E) but was found to represent a cluster of EPVS
on T2w MRI (F). A focal area of low attenuation observed on CT was identified as a noncavitated lacunar lesion (G); this was considered to be a WMH
on FLAIR MRI (H). All assessments of old infarct agreement was based on data from 1 rater.
ARTICLE IN PRESS
WMH AND ATROPHY RATINGS IN CT AND MRI 3
Visual Rating Scales
Weighted Kappa statistics for agreement between CT
and MRI, and inter-rater and intrarater reliabilities are
shown in Table 1.
CT Versus MRI
For both raters, weighted Kappas indicated moderate
to substantial agreement between most WMH and most
atrophy scores between CT and MRI (Κ = .43-.70 for Raters
1 and 2). The exception was the ARWMC basal ganglia
scores for Rater 2, which showed lower agreement between
CT versus MRI with consistently higher MRI scoring com-
pared with CT. A lower Kappa for this scale (Κ = .44) by
Rater 1 compared with the other WMH scales also re-
flected higher MRI scores. McNemar’s tests were
nonsignificant for CT versus MRI scoring by Rater 1.
McNemar’s tests were significant for most scales for Rater
2 (ARWMC frontal: χ2 = 4.55; P = .033; ARWMH parieto-
occipital: χ2 = 5.54; P = .018; ARWMH basal ganglia:
χ2 = 13.33; P = .0003; Van Swieten anterior: χ2 = 8.00;
P = .0047; Van Swieten posterior: χ2 = 8.90; P = .0029;
Fazekas’ periventricular: χ2 = 8.00; P = .0047; Fazekas’ deep
white matter: χ2 = 5.26; P = .022) consistent with higher
scoring on MRI by this rater compared with CT.
CT Versus CT (Inter-Rater)
Inter-rater agreements within CT were substantial for
periventricular aspects of all the scales used (Κ = .63-
.75). Moderate agreement was achieved in Fazekas’ deep
WMH scores and for both atrophy scales (Κ = .50, .45,
and .47). The ARWMC basal ganglia scores showed fair
agreement (Κ = .28) attributed to higher scoring within
CT by Rater 1 compared with Rater2. McNemar’s tests
were significant for some scales (ARWMH basal ganglia:
χ2 = 26.13, P < .001; Van Swieten anterior: χ2 = 17.00, P < .001;
Van Swieten posterior: χ2 = 12.56, P = .0014; superficial
atrophy: χ2 = 18.67, P < .001), reflecting higher rating by
Rater 1 compared with Rater 2.
CT Versus CT (Intra-Rater)
Intrarater agreements were mostly in the range of
Kappa = .65-.78, indicating substantial agreement except
for the ARWMC basal ganglia score, which showed mod-
erate agreement (Kappa = .55). Higher scores were given
generally when rated for the first time, resulting in several
significant McNemar’s tests (ARWMC basal ganglia:
χ2 = 4.17, P = .041; posterior van Swieten: χ2 = 9.80, P = .0017;
periventricular Fazekas: χ2 = 5.00, P = .025; and deep
Fazekas’ scores: χ2 = 6.00, P = .0014), possibly reflecting
a training effect. A better intrarater basal ganglia agree-
ment compared with inter-rater comparisons suggests a
difference in the application of the scale by the 2 raters.
Old Infarcts
One rater determined that 47 patients exhibited old in-
farcts, with 130 lesions in total coded on MRI, CT, or both
modalities. Of these lesions, 27 were cortical and 103
lacunar (54 cavitated). Table 2 shows the frequency of
agreement for cortical infarcts and cavitated and
noncavitated lacunes. Cortical lesions showed the highest
rate of “perfect agreement” in both MRI and CT (48%)
followed by cavitated lacunar lesions (33%). Only 10%
of noncavitated lacunar lesions were correctly identified
on both MRI and CT. The most frequent reason for failure
to identify lesions was size, with 26% of cortical lesions,
33% of noncavitated lacunar lesions, and 35% of cavi-
tated lacunar lesions identified on MRI but not visible
or (in the case of lacunes) below the size threshold (≤3 mm)
for inclusion on CT. Analysis of volume data for all lacunar
lesions indicated that lesions observed on both modali-
Table 1. Weighted Kappa statistics for agreement between CT and MRI, and inter-rater and intrarater reliabilities
Rater 1 CT
versus MRI
(95% CI)
Rater 2 CT
versus MRI
(95% CI)
Rater 1 versus Rater 2
inter-rater within CT
(95% CI)
Rater1 intrarater
within CT
(95% CI)
ARWMC frontal .58 (.45-.72) .70 (.60-.81) .74 (.63-.84) .73 (.61-.85)
ARWMC parieto-occipital .61 (.49-.74) .65 (.53-.77) .75 (.64-.86) .73 (.62-.83)
ARWMC basal ganglia .44 (.27-.60) .18 (.02-.34) .28 (.13-.42) .55 (.40-.70)
van Swieten anterior .67 (.52-.81) .60 (.44-.75) .65 (.52-.79) .78 (.66-.90)
van Swieten posterior .66 (.53-.79) .62 (.47-.77) .63 (.51-.75) .69 (.57-.81)
Fazekas periventricular .68 (.55-.80) .55 (.42-.68) .69 (.59-.80) .75 (.64-.85)
Fazekas deep white matter .57 (.43-.70) .70 (.58-.81) .50 (.35-.64) .67 (.54-.79)
Superficial atrophy .61 (.49-.73) .43 (.25-.61) .45 (.32-.58) .65 (.53-.77)
Deep atrophy .70 (.59-.81) .53 (.40-.66) .47 (.34-.60) .65 (.54-.77)
Abbreviations: ARWMC, Age-Related White Matter Change; CT, computed tomography; MRI, magnetic resonance imaging.
Kappas (95% CI) with linear weighting showing agreement for both raters between CT and MRI, inter-rater agreement within CT, and
intrarater agreement for WMH and atrophy scores. Intra-rater reliability for CT scoring was performed by 1 rater (Rater 1).
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ties had a mean volume of 314.38 mm3 when measured
on MRI, but the mean volume of the same lesions mea-
sured on CT was only 239.62 mm3, consistent with the
lower sensitivity of CT to subtle tissue changes.
The mean volume of lesions identified on MRI but un-
detected on CT was very small at 107.23 mm3. Some infarcts
were observed in both modalities but were coded dif-
ferently due to a perceived different location or extent,
with lesions appearing larger on MRI (11% cortical, 2%
noncavitated lacunar, 9% cavitated lacunar). Other lesions
were observed on both modalities but were only classed
as infarcts on 1. This occurred most frequently where
lacunes observed on CT were not recorded as WMH on
MRI, accounting for 41% of presumed noncavitated and
17% of cavitated lesions. In other situations, basal ganglia
“infarcts” were recorded on CT but on MRI were found
to be clusters of enlarged perivascular spaces (PVS). There
was some confusion between old lesions and acute lesions,
particularly cortical infarcts of which 11% were misclassified
on CT, with DWI MRI allowing better discrimination.
Discussion
The main findings of this study are that standardized
visual rating scales of white matter lesions and atrophy
mostly show good agreement between CT and MRI. Ad-
ditionally, larger and cavitated old infarcts seen on MRI
could be reliably identified on CT. Only 1 measure
(ARWMC scale basal ganglia rating) was performing at
less-than-moderate agreement for intrarater analysis on
comparing the different modalities and also for inter-
rater results on CT. This is the largest study examining
visual ratings of atrophy, and is of comparable size to a
prior study of visual ratings in CT and MRI5 and also
adds new analyses of CT versus MRI in the detection
and classification of old infarcts. The present findings
support the use of clinical CT scans as a research tool
assessing how white matter lesions and brain atrophy con-
tribute to risk and outcomes. The use of clinical CT has
particular value in studies of large numbers of acutely
unwell patients in which MRI studies would not be
practical.
Some scales showed better inter-rater agreement between
CT and MRI than others. In particular, subscales for rating
periventricular lesions appeared to be more reliable. This
is perhaps because periventricular lesions are easier to
visualize and the areas of low attenuation surrounding
the ventricles are less ambiguous than lesions in the deep
white matter and basal ganglia. In contrast, there was
poorer agreement in scoring where deep gray tissue was
rated separately, such as the ARWMC basal ganglia scores.
In these areas, PVS are common, are concomitant with
other features of small vessel disease,13 and are easily vi-
sualized on T2–weighted MRI but are difficult to resolve
on CT. When PVS are prevalent, “normal” WM appears
less attenuated on CT and clusters of PVS may resem-
ble larger lesions, making interpretation in deeper areas
harder. Tissue signal changes surrounding lesions may
make lesions on MRI appear confluent, whereas they seem
discrete on CT. In addition, differences in the interpre-
tation of the scale, with ambiguous definitions for some
grades such as “beginning of confluence of foci,” may
have reduced consistency between raters. A recent study14
in which ambiguity was reduced by providing more spe-
cific operational definitions for each score in the ARWMC
scale resulted in improved reliability compared with the
performance of the original scale (for example, for inter-
rater reliability on CT Kappa = .87 for the operational scale
compared with Kappa = .57 for the original scale).
Higher sensitivity to WMH on FLAIR reduces agree-
ment between CT and MRI. Consistent with this, previous
studies demonstrated increased sensitivity for WMH de-
tection by MRI.6,7 In the present study, Rater 2 consistently
rated MRI higher as confirmed by significant McNemar’s
tests. Interestingly, inter-rater agreement for within-CT
scoring tended to be higher than CT versus MRI, sug-
gesting that differences between raters contributed to
discrepancies less than variations between the modalities.
Kappa values tended to be lower for atrophy ratings
than most WMH scoring. The 5-point scale used for
Table 2. Agreement between CT and MRI coding for cortical, noncavitated lacunar, and cavitated lacunar lesions
Cortical
Noncavitated
lacunar
Cavitated
lacunar
Perfect agreement 48 10 33
Identified as an infarct on both modalities but coded differently (territory or size) 11 2 9
Visible on both modalities but identified as an infarct on 1 only (e.g., confusion
with WMH)
4 41 17
Not coded on 1 modality (below size threshold or not visible) 26 41 39
Confusion between old/acute 11 4 2
Missed (identified on review) 0 2 0
Abbreviations: CT, computed tomography; MRI, magnetic resonance imaging; WMH, white matter hyperintensity.
The frequency (expressed as percentages) of coding agreement or misclassification for cortical, noncavitated lacunar, and cavitated lacunar
lesions.
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atrophy measures here results in a greater range in scores
than in the other scales, possibly affecting Kappa values.
One published study4 achieved better agreement in atrophy
rating, although this study used a 4-point scale and as-
sessed atrophy globally rather than distinguishing between
deep and superficial aspects.
Larger cortical and cavitated lacunar lesions were re-
liably seen on both CT and MRI scans. However, smaller
lesions tended to be missed on CT possibly due to the
low threshold of inclusion for lacunar lesions (≥3 mm)
and lower sensitivity to small cortical lesions. Lesions
appear larger on MRI because it is more sensitive to subtle
changes in the surrounding tissue. This was apparent when
comparing the calculated volumes of the same lesions
on both modalities (239.62 mm3 in CT versus 314.38 mm3
in MRI). Some smaller cortical lesions were visible on MRI
due to signal intensity changes, but with little discern-
ible structural change, they were difficult to detect on CT.
Identification of noncavitated lesions on CT was prob-
lematic with a high degree of overlap with WMH. This
replicates findings of a survey of researchers of small vessel
disease in which cavitated lesions (lacunes) were more
likely to be identified as lacunar stroke lesions than
noncavitated lesions (63% versus 7.8%, respectively) and
noncavitated lesions were only classified as lacunar strokes
if they were large and if WMHs were absent.15
Simplification of coding (fewer categories, collapsing
territories) may also improve reliability for nonexperts
or routine clinical applications where location is of less
relevance than simply identifying that a lesion exists and
its type. In the method used in this study, there are cur-
rently different codes for basal ganglia, thalamic, centrum
semiovale, and internal border zone lacunar infarcts derived
from a research classification and relevant to future studies
of delirium or dementia and lesion location. However,
reduced contrast among deep structures on CT and dif-
ferences in scan orientation can make correct coding
difficult. Additionally, determining the size of cortical in-
farcts can be subjective and lead to errors, particularly
in the case of cortical infarcts that appear larger on MRI
due to changes in surrounding tissue. Also on CT, while
many acute and old lesions can be easily differentiated,
less expert reviewers may find it more difficult to dif-
ferentiate some old from some recent lesions, whereas
on MRI diffusion imaging makes it very obvious which
is the acute lesion. The error would not be relevant in a
nonstroke population.
There were some limitations in this study. Kappa sta-
tistics were used to evaluate the magnitude of agreement.
A limitation of Kappa is that it is susceptible to the prev-
alence of observations, number of categories, and sample
size. The tests of marginal homogeneity indicated sym-
metry and bias but did not give an indication of the
magnitude of agreement. The scans analyzed in this study
were performed in acute stroke patients, and there was
mild movement artifact in some scans (although very poor
scans were excluded), yet despite this it was still possi-
ble to analyze all the images, but scan quality may have
accounted for some discrepancy in grading between CT
and MRI scans. On the other hand, this is typical of most
delirious or long-term cognitively impaired patients at
hospital admission.
In conclusion, the present findings facilitate greater ex-
ploitation of clinical CT in studying atrophy and white
matter lesions in acute illness or in patients with
contraindications to MRI. Multiple scientific questions could
be tested, including (1) global and regional atrophy and
WMHs as predictors of clinical outcome; (2) associa-
tions between old infarcts and clinical outcome; (3)
longitudinal change (with second scans); and (4) CT mea-
sures of brain pathology as independent determinants of
longer-term outcomes (e.g., institutionalization). There-
fore, CT may be an important tool for understanding the
neural substrates of conditions that affect older people
and are difficult to research using MRI. The identifica-
tion of more robust visual rating methods could potentially
improve consistency and reliability in the reporting of
clinical scans.
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